AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)
AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)

Balance Sheet ACST Quote Acasti Phar

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 1 1 3
ShortTermInvest 23 17 7
Cash 24 18 10
AccountReceivab 0 0 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 1 1 0
TotalCurrentAss 26 20 11
PPE 0 0 0
AccumulatedDepr 0 0 0
NetPPE 0 0 0
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 20 17 15
OtherLTAssets 0 0 2
TotalNonCurrent 20 18 17
TotalAssets 46 37 29
ShortTermDebt 0 0 0
AccountsPayable 0 0 0
TaxesPayable 0 0 0
AccruedLiabilit 0 0 0
DeferredRevenue 0 0 0
OtherCurrentLia 1 1 1
TotalCurrentLia 1 2 1
Debt 0 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 11 2 0
TotalNonCurrent 11 2 0
TotalLiabilitie 12 4 1
CommonStock 0 0 0
AdditionalPaidI 65 67 67
RetainedEarning -32 -33 -40
AccumulatedOthe 0 0 0
TotalStockholde 33 33 27
TotalLiabilitie 46 37 29
Acasti Pharma Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Acasti Pharma Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.